These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 23301708)
1. Precision medicine and the rapidly approaching future of cancer management. Markman M Am J Manag Care; 2012 Dec; 18(5 Spec No.):SP207-8, cover. PubMed ID: 23301708 [No Abstract] [Full Text] [Related]
2. Paul Workman: Drugging the Cancer Genome. Trends Cancer; 2016 Oct; 2(10):544-548. PubMed ID: 27904887 [No Abstract] [Full Text] [Related]
4. New ESMO scale ranks mutations as cancer medicine targets. Fricker J Lancet Oncol; 2018 Oct; 19(10):e513. PubMed ID: 30177495 [No Abstract] [Full Text] [Related]
5. Delivering on the promise of precision cancer medicine. Berger MF; Van Allen EM Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852 [No Abstract] [Full Text] [Related]
6. BRAF molecular testing in cytopathology: Implications for diagnosis, prognosis, and targeted therapeutics. Bergdorf KN; Lee LA; Weiss VL Cancer Cytopathol; 2020 Jan; 128(1):9-11. PubMed ID: 31765065 [No Abstract] [Full Text] [Related]
7. Targeted therapies: What have we learned from SHIVA? Le Tourneau C; Kurzrock R Nat Rev Clin Oncol; 2016 Dec; 13(12):719-720. PubMed ID: 27725677 [No Abstract] [Full Text] [Related]
8. Precision Medicine in Pediatric Oncology. Vo KT; Parsons DW; Seibel NL Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314 [TBL] [Abstract][Full Text] [Related]
9. Precision cancer medicine: where to target? Yu Q; Ding J Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154 [No Abstract] [Full Text] [Related]
10. The SHIVA01 trial: what have we learned? Le Tourneau C; Kamal M; Bièche I Pharmacogenomics; 2017 Jun; 18(9):831-834. PubMed ID: 28594293 [No Abstract] [Full Text] [Related]
11. Precision Medicine and Targeted Therapies in Breast Cancer. Greenwalt I; Zaza N; Das S; Li BD Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313 [TBL] [Abstract][Full Text] [Related]
12. Perspective on Precision Medicine in Oncology. Johnson TM Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968 [TBL] [Abstract][Full Text] [Related]
13. Genomics and the History of Precision Oncology. Doroshow DB; Doroshow JH Surg Oncol Clin N Am; 2020 Jan; 29(1):35-49. PubMed ID: 31757312 [TBL] [Abstract][Full Text] [Related]
14. DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance? Voest EE; Bernards R Cancer Discov; 2016 Feb; 6(2):130-2. PubMed ID: 26851184 [TBL] [Abstract][Full Text] [Related]
15. An update on genomic-guided therapies for pediatric solid tumors. Tsui PC; Lee YF; Liu ZWY; Ip LRH; Piao W; Chiang AKS; Lui VWY Future Oncol; 2017 Jun; 13(15):1345-1358. PubMed ID: 28589766 [TBL] [Abstract][Full Text] [Related]
16. NCI-MATCH launch highlights new trial design in precision-medicine era. McNeil C J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446 [No Abstract] [Full Text] [Related]
17. Session 2: Mutational discordance: the big challenge in personalized treatments - any solutions? Siddiqui M; Chand M; Eng C; Mehdizadeh A; Mirnezami A; Brown G Colorectal Dis; 2018 May; 20 Suppl 1():49-51. PubMed ID: 29878676 [TBL] [Abstract][Full Text] [Related]
18. New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy. Bao J; Qiao L Cancer Lett; 2017 Feb; 387():1-2. PubMed ID: 28038727 [No Abstract] [Full Text] [Related]
19. Pairing Cancer Biomarkers to Biomedicine. Shin SH; Dong Z EBioMedicine; 2017 Nov; 25():1-2. PubMed ID: 29113773 [No Abstract] [Full Text] [Related]